Vagus Nerve Stimulation Boosts Brain Function

Working memory deficits are a common and often debilitating feature of several neurological and hearing-related conditions. A study from the University of Sheffield used high-density functional near-infrared spectroscopy (HD-fNIRS) to investigate whether transcutaneous auricular vagus nerve stimulation (taVNS) could modulate brain activity during a demanding cognitive task. The research, published in *Experimental Brain Research*, provides a detailed look at cortical blood flow but found no significant effect from active stimulation compared to a sham under its specific protocol.

Measuring Brain Activity with Light During Cognitive Challenge

To understand if taVNS affects working memory circuits, the team needed a method to measure brain activity in real-time while participants were stimulated. They chose high-density functional near-infrared spectroscopy (HD-fNIRS). This non-invasive technique uses light to measure changes in oxygenated hemoglobin (HbO) in the blood, which serves as a proxy for neural activity. It allows participants to sit upright and move slightly, making it ideal for studies combining tasks with devices like taVNS.

The study involved 22 healthy adults. Each participant performed a computerized 3-back working memory task, where they had to indicate if a current letter matched the one presented three steps earlier. This task heavily engages the prefrontal cortex. While they performed the task in blocks, researchers recorded from 1728 channels across the bilateral prefrontal cortex using a cap fitted with 36 light sources and 48 detectors.

A Direct Comparison of Active and Sham Stimulation

The methodology was designed for a clear comparison. All participants underwent two trials of the 3-back task. In the first trial, they received sham transcutaneous vagus nerve stimulation (tVNS) applied to the earlobe—an area not innervated by the vagus nerve. In the second trial, they received active taVNS applied to the tragus of the ear, a common site for targeting auricular vagus nerve fibers. Brain activity was compared both within each trial (task versus baseline) and between the two trials (active versus sham).

This approach is common in neuromodulation research to control for placebo effects. However, the authors of the paper (DOI: 10.1007/s00221-026-07354-2) explicitly caution that using a fixed order—always sham first, then active—is a limitation. Fatigue or habituation to the task on the second try could mask a true effect of the stimulation.

Task Activates Brain, But Stimulation Shows No Added Effect

The fNIRS data revealed a clear and robust pattern of brain activation caused by the working memory task itself. As expected, task-related increases in blood flow occurred in regions critical for executive function: the right dorsolateral middle frontal gyri, left inferior frontal gyrus, and right lateral orbitofrontal cortex. Simultaneously, decreases were observed in the bilateral superior medial frontal gyri and medial orbital frontal cortices, areas often associated with the brain’s default mode network that quiets down during focused tasks.

The central question, however, was whether active taVNS changed this pattern. The analysis showed no significant differences in cortical activity between the active and sham stimulation trials. The brain’s response to the cognitive challenge looked the same regardless of where the mild electrical stimulation was applied. Similarly, there was no difference in how accurately or quickly participants performed the 3-back task between the two conditions.

Implications for Research and Clinical Practice

The primary outcome of this study is methodological. It demonstrates that simultaneously recording HD-fNIRS during a cognitive task and taVNS is not only possible but well-tolerated by participants. This opens the door for more complex studies in patient groups where such combined approaches were previously difficult. For example, this technique could be applied to study cognitive decline in hearing loss patients or the neural basis of conditions like misophonia, where transcutaneous auricular vagus nerve stimulation is being investigated as a potential treatment.

The lack of a stimulating effect under these specific parameters is not a final verdict on taVNS for cognition. As the researchers note, different stimulation intensities, durations, or timing relative to the task could yield different results. The study underscores the complexity of neuromodulation and the importance of rigorous trial design. It also highlights the value of tools like HD-fNIRS in brain imaging advances for hearing disorder research, allowing scientists to directly observe whether an intervention alters targeted brain networks.

For clinicians and patients, this study represents a careful step in the evidence-gathering process. It suggests that a simple, short application of taVNS may not be sufficient to boost working memory performance in a healthy brain during a single session. Future research must determine if different protocols, longer-term training, or use in clinical populations with known deficits—where there may be more room for improvement—can produce a measurable benefit.